astragaloside a has been researched along with alpha-asarone in 1 studies
| Studies (astragaloside a) | Trials (astragaloside a) | Recent Studies (post-2010) (astragaloside a) | Studies (alpha-asarone) | Trials (alpha-asarone) | Recent Studies (post-2010) (alpha-asarone) |
|---|---|---|---|---|---|
| 675 | 5 | 573 | 286 | 1 | 184 |
| Protein | Taxonomy | astragaloside a (IC50) | alpha-asarone (IC50) |
|---|---|---|---|
| 3-hydroxy-3-methylglutaryl-coenzyme A reductase | Homo sapiens (human) | 2.9482 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hu, K; Liu, M; Ni, S; Sun, L; Wang, J; Xu, X; Zhao, X | 1 |
1 other study(ies) available for astragaloside a and alpha-asarone
| Article | Year |
|---|---|
Nose to brain delivery of Astragaloside IV by β-Asarone modified chitosan nanoparticles for multiple sclerosis therapy.
Topics: Animals; Brain; Chitosan; Disease Models, Animal; Mice; Multiple Sclerosis | 2023 |